Status:

WITHDRAWN

Effect of Remote Intervention in Patients With SCAD

Lead Sponsor:

Chinese Academy of Medical Sciences, Fuwai Hospital

Conditions:

Stable Chronic Angina

Ischemic Heart Disease

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

The study was a multicenter, two-arm, parallel, open-label, prospective clinical trial that evaluated a remote intervention with 1 year of follow-up.

Detailed Description

Objective: This study is intended to verify the effect of a remote intervention on adherence to drugs and risk factors control in patients with stable coronary artery disease. Study design: The study...

Eligibility Criteria

Inclusion

  • Aged between 18-99 years
  • Diagnosed with SCAD according to guidelines by coronary CTA or coronary angiography (including stable angina, ischemic cardiomyopathy, and the stable course after acute coronary syndrome)
  • Have sufficient Chinese language proficiency to reading, speaking and listening
  • Live with at least one caregiver or guardian in the household
  • Presence of stable hemodynamics without using vasopressor
  • Able to individually consent
  • Not participating in any other clinical trial

Exclusion

  • Unable to provide informed consent
  • Unable to be involved in clinical follow-up and treatment
  • Suffered comorbidity with a life expectancy of less than 1 year
  • Have contra-indication to cardiac rehabilitation
  • Acute coronary syndrome
  • History of noncompliance with medical therapy
  • Severe valvular disease or valvular disease likely to require surgery or percutaneous valve replacement during the trial
  • Planned major surgery necessitating interruption of antiplatelet therapy
  • Inability to comply with the protocol
  • Has any condition that, in the opinion of the investigator, would make participation not be in the best interest of the subject or that could prevent, limit or confound the protocol-specified assessments

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04795492

Start Date

April 1 2021

End Date

April 1 2023

Last Update

February 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fuwai Hospital, Chinese Academy of Medical Science; National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, China, 100000